LENOXe™: xenon for anesthesia [ Return towards  Health  ]

Air Liquide has developed LENOXe™, the first xenon-based anesthesic device. This innovation means faster recovery for the patient, even after lengthy operations.

Patients often have trouble recovering from the anesthesia they are administered during a surgery. To facilitate this recovery, Air Liquide has developed the first xenon-based anesthetic agent.

A gas present in very small quantities in the air (less than 0.09 ppm), xenon has remarkable anesthetic properties. Xenon is an inert gas that is not metabolized by the organism. It acts on specific brain receptors that it will “inhibit”, inducing a state of anesthesia, with complete suspension of muscle movement, amnesia and the suppression of  pain sensation.

Breathed in during the surgery, mixed with oxygen, LENOXe™ is a genuine innovation in the anesthetics field, in particular for lengthy operations. The patient wakes up quickly and his recovery is facilitated after the surgery, even if it lasted several hours.

To efficiently administer LENOXe™, Air Liquide has developed and made available to hospitals FELIX DUAL, a new anesthesia workstation that enables delivery of LENOXe™, and of other more traditional products as well like nitrous oxide and other inhaled anesthetic agents.

Company

Contact

For any further information, contact us:

  • By mail :

Nathalie Simon de Kergunic

1 Chemin de la Porte des Loges

Les Loges en Josas

BP 126 - 78350 Jouy en Josas - France

Please, fill the form

Click Here